Kidney Disease: Improving Global Outcomes (KDIGO) released the 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD). Released 2 years after the first KDIGO guideline on this subject, the updated guideline applies to a broad population of patients with diabetes and CKD. The guideline addresses type 1 and type 2 diabetes and highlights differences in approach to management when appropriate. The short interval between guidelines reflects the rapid pace of advancement in the treatment of diabetes and CKD. The new guideline, an Executive Summary, and additional resources are available online.
